Last update Feb. 15, 2016
Likely Compatibility
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
C16H19BrN2 is Brompheniramine Maleate in Molecular formula.
Is written in other languages:C16H19BrN2 is also known as
Main tradenames from several countries containing C16H19BrN2 in its composition:
Variable | Value | Unit |
---|---|---|
Oral Bioavail. | 100 | % |
Molecular weight | 435 | daltons |
VD | 11.7 | l/Kg |
Tmax | 3 | hours |
T½ | 25 | hours |
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2015 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
First generation antihistamine, alkylamine drug, sedative with antimuscarinic effect.
Described irritability, crying and insomnia in a baby from a nursing mother after taking a preparation compounded by Iso-ephedrine and brompheniramine that were possibly responsible for the symptoms.
Check up the occurrence of drowsiness and inappropriate feeding of the infant.
Likely inhibition of breastfeeding in the first weeks after birth due to anti-prolactin effect.
It is not recommended bed-sharing with the baby if you are on this medication.